Annual D&A
$487.00 K
+$52.00 K+11.95%
December 31, 2022
Summary
- As of February 7, 2025, ARDS annual depreciation & amortization is $487.00 thousand, with the most recent change of +$52.00 thousand (+11.95%) on December 31, 2022.
- During the last 3 years, ARDS annual D&A has risen by +$149.00 thousand (+44.08%).
- ARDS annual D&A is now at all-time high.
Performance
ARDS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$59.00 K
-$4000.00-6.35%
September 30, 2023
Summary
- As of February 7, 2025, ARDS quarterly depreciation & amortization is $59.00 thousand, with the most recent change of -$4000.00 (-6.35%) on September 30, 2023.
- Over the past year, ARDS quarterly D&A has dropped by -$4000.00 (-6.35%).
- ARDS quarterly D&A is now -62.42% below its all-time high of $157.00 thousand, reached on December 31, 2021.
Performance
ARDS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$309.00 K
-$66.00 K-17.60%
September 30, 2023
Summary
- As of February 7, 2025, ARDS TTM depreciation & amortization is $309.00 thousand, with the most recent change of -$66.00 thousand (-17.60%) on September 30, 2023.
- Over the past year, ARDS TTM D&A has dropped by -$66.00 thousand (-17.60%).
- ARDS TTM D&A is now -43.20% below its all-time high of $544.00 thousand, reached on September 30, 2022.
Performance
ARDS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ARDS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.9% | -6.3% | -17.6% |
| 3 y3 years | +44.1% | -30.6% | -8.3% |
| 5 y5 years | +685.5% | -32.2% | -8.6% |
ARDS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.9% | -62.4% | at low | -43.2% | at low |
| 5 y | 5-year | at high | +44.5% | -62.4% | at low | -43.2% | at low |
| alltime | all time | at high | +2017.4% | -62.4% | +1080.0% | -43.2% | +6080.0% |
Aridis Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $59.00 K(-6.3%) | $309.00 K(-17.6%) |
| Jun 2023 | - | $63.00 K(-27.6%) | $375.00 K(-15.3%) |
| Mar 2023 | - | $87.00 K(-13.0%) | $443.00 K(-9.0%) |
| Dec 2022 | $487.00 K(+12.0%) | $100.00 K(-20.0%) | $487.00 K(-10.5%) |
| Sep 2022 | - | $125.00 K(-4.6%) | $544.00 K(+6.0%) |
| Jun 2022 | - | $131.00 K(0.0%) | $513.00 K(+8.0%) |
| Mar 2022 | - | $131.00 K(-16.6%) | $475.00 K(+9.2%) |
| Dec 2021 | $435.00 K(+29.1%) | $157.00 K(+67.0%) | $435.00 K(+19.8%) |
| Sep 2021 | - | $94.00 K(+1.1%) | $363.00 K(+2.5%) |
| Jun 2021 | - | $93.00 K(+2.2%) | $354.00 K(+2.9%) |
| Mar 2021 | - | $91.00 K(+7.1%) | $344.00 K(+2.1%) |
| Dec 2020 | $337.00 K | $85.00 K(0.0%) | $337.00 K(0.0%) |
| Sep 2020 | - | $85.00 K(+2.4%) | $337.00 K(-0.6%) |
| Jun 2020 | - | $83.00 K(-1.2%) | $339.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $84.00 K(-1.2%) | $339.00 K(+0.3%) |
| Dec 2019 | $338.00 K(+19.4%) | $85.00 K(-2.3%) | $338.00 K(+0.6%) |
| Sep 2019 | - | $87.00 K(+4.8%) | $336.00 K(+3.4%) |
| Jun 2019 | - | $83.00 K(0.0%) | $325.00 K(+3.2%) |
| Mar 2019 | - | $83.00 K(0.0%) | $315.00 K(+11.3%) |
| Dec 2018 | $283.00 K(+356.5%) | $83.00 K(+9.2%) | $283.00 K(+18.9%) |
| Sep 2018 | - | $76.00 K(+4.1%) | $238.00 K(+35.2%) |
| Jun 2018 | - | $73.00 K(+43.1%) | $176.00 K(+63.0%) |
| Mar 2018 | - | $51.00 K(+34.2%) | $108.00 K(+74.2%) |
| Dec 2017 | $62.00 K(+169.6%) | $38.00 K(+171.4%) | $62.00 K(+158.3%) |
| Sep 2017 | - | $14.00 K(+180.0%) | $24.00 K(+140.0%) |
| Jun 2017 | - | $5000.00(0.0%) | $10.00 K(+100.0%) |
| Mar 2017 | - | $5000.00 | $5000.00 |
| Dec 2016 | $23.00 K | - | - |
FAQ
- What is Aridis Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals annual D&A year-on-year change?
- What is Aridis Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly D&A year-on-year change?
- What is Aridis Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals TTM D&A year-on-year change?
What is Aridis Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ARDS is $487.00 K
What is the all time high annual D&A for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual depreciation & amortization is $487.00 K
What is Aridis Pharmaceuticals annual D&A year-on-year change?
Over the past year, ARDS annual depreciation & amortization has changed by +$52.00 K (+11.95%)
What is Aridis Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ARDS is $59.00 K
What is the all time high quarterly D&A for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly depreciation & amortization is $157.00 K
What is Aridis Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ARDS quarterly depreciation & amortization has changed by -$4000.00 (-6.35%)
What is Aridis Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ARDS is $309.00 K
What is the all time high TTM D&A for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high TTM depreciation & amortization is $544.00 K
What is Aridis Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ARDS TTM depreciation & amortization has changed by -$66.00 K (-17.60%)